• Home
  • Stock
  • Aarti Pharmalabs Fundamental Analysis
  • Aarti Pharmalabs Fundamental Analysis

Aarti Pharmalabs fundamental analysis

AARTIPHARM

HealthcareMid

728.9

5.45 (0.75%)
Last updated on 6 Dec, 2025 | 14:05 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Aarti Pharmalabs Fundamentals

P/E Ratio

27.3

P/B Ratio

3.2

Div. Yield

0.69

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 27.3, compared to the sector average of 36.18. Its P/B Ratio stands at 3.2, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0.69%, which is than the sector’s 0.56%.

Aarti Pharmalabs Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Aarti Pharmalabs reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.